▶ 調査レポート

分子診断キットの世界市場2023年:PCR、遺伝子チップ、蛍光insituハイブリダイゼーション、DNAシーケンス

• 英文タイトル:Global Molecular Diagnostic Kits Market Research Report 2023

QYResearchが調査・発行した産業分析レポートです。分子診断キットの世界市場2023年:PCR、遺伝子チップ、蛍光insituハイブリダイゼーション、DNAシーケンス / Global Molecular Diagnostic Kits Market Research Report 2023 / MRC23Q37930資料のイメージです。• レポートコード:MRC23Q37930
• 出版社/出版日:QYResearch / 2023年3月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥429,200 (USD2,900)▷ お問い合わせ
  Enterprise License¥858,400 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界の分子診断キット市場について調査・分析し、世界の分子診断キット市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析(PCR、遺伝子チップ、蛍光insituハイブリダイゼーション、DNAシーケンス)、用途別セグメント分析(感染症診断、遺伝子診断、血液検査、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Roche、Danaher、Hologic、Grifols、BioMérieux、Qiagen、Abbott、Thermo Fisher、Bio-Rad、Illumina、Siemens、Agilent、Daangene、Diasorin、Merck、KHB、liferiver、Leadmanなどが含まれています。世界の分子診断キット市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争の影響は、分子診断キット市場規模を推定する際に考慮しました。本レポートは、分子診断キットの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、分子診断キットに関するビジネス上の意思決定に役立てることを目的としています。

・分子診断キット市場の概要
- 製品の定義
- 分子診断キットのタイプ別セグメント
- 世界の分子診断キット市場規模:タイプ別分析(PCR、遺伝子チップ、蛍光insituハイブリダイゼーション、DNAシーケンス)
- 分子診断キットの用途別セグメント
- 世界の分子診断キット市場規模:用途別分析(感染症診断、遺伝子診断、血液検査、その他)
- 世界の分子診断キット市場規模予測(2018年-2029年)
- 分子診断キットの平均価格推移(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 分子診断キット市場の競争状況およびトレンド

・分子診断キットの地域別市場規模
- 北米の分子診断キット市場規模(2018年-2029年)
- アメリカの分子診断キット市場規模(2018年-2029年)
- ヨーロッパの分子診断キット市場規模(2018年-2029年)
- アジア太平洋の分子診断キット市場規模(2018年-2029年)
- 中国の分子診断キット市場規模(2018年-2029年)
- 日本の分子診断キット市場規模(2018年-2029年)
- 韓国の分子診断キット市場規模(2018年-2029年)
- インドの分子診断キット市場規模(2018年-2029年)
- オーストラリアの分子診断キット市場規模(2018年-2029年)
- 中南米の分子診断キット市場規模(2018年-2029年)
- 中東・アフリカの分子診断キット市場規模(2018年-2029年)

・タイプ別セグメント:PCR、遺伝子チップ、蛍光insituハイブリダイゼーション、DNAシーケンス
- 世界の分子診断キットのタイプ別販売量(2018年-2023年)
- 世界の分子診断キットのタイプ別売上(2018年-2023年)
- 世界の分子診断キットのタイプ別価格

・用途別セグメント:感染症診断、遺伝子診断、血液検査、その他
- 世界の分子診断キットの用途別販売量(2018年-2023年)
- 世界の分子診断キットの用途別売上(2018年-2023年)
- 世界の分子診断キットの用途別価格

・主要企業のプロファイル:企業情報、事業概要、売上、製品ポートフォリオ、動向
Roche、Danaher、Hologic、Grifols、BioMérieux、Qiagen、Abbott、Thermo Fisher、Bio-Rad、Illumina、Siemens、Agilent、Daangene、Diasorin、Merck、KHB、liferiver、Leadman

・産業チェーンと販売チャネルの分析
- 分子診断キット産業チェーン分析
- 分子診断キットの主要原材料
- 分子診断キットの販売チャネル
- 分子診断キットのディストリビューター
- 分子診断キットの主要顧客

・分子診断キット市場ダイナミクス
- 分子診断キットの業界動向
- 分子診断キット市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Molecular Diagnostic Kits market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Molecular Diagnostic Kits is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Molecular Diagnostic Kits is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Molecular Diagnostic Kits include Roche, Danaher, Hologic, Grifols, BioMérieux, Qiagen, Abbott, Thermo Fisher and Bio-Rad, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Kits.
The Molecular Diagnostic Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Molecular Diagnostic Kits market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Roche
Danaher
Hologic
Grifols
BioMérieux
Qiagen
Abbott
Thermo Fisher
Bio-Rad
Illumina
Siemens
Agilent
Daangene
Diasorin
Merck
KHB
liferiver
Leadman
Segment by Type
PCR
Gene Chip
Fluorescence in Situ Hybridization
DNA Sequencing
Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostic Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostic Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

レポート目次

1 Molecular Diagnostic Kits Market Overview
1.1 Product Overview and Scope of Molecular Diagnostic Kits
1.2 Molecular Diagnostic Kits Segment by Type
1.2.1 Global Molecular Diagnostic Kits Market Value Comparison by Type (2023-2029)
1.2.2 PCR
1.2.3 Gene Chip
1.2.4 Fluorescence in Situ Hybridization
1.2.5 DNA Sequencing
1.3 Molecular Diagnostic Kits Segment by Application
1.3.1 Global Molecular Diagnostic Kits Market Value by Application: (2023-2029)
1.3.2 Infectious Disease Diagnosis
1.3.3 Genetic Diagnosis
1.3.4 Blood Screening
1.3.5 Other
1.4 Global Molecular Diagnostic Kits Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostic Kits Revenue 2018-2029
1.4.2 Global Molecular Diagnostic Kits Sales 2018-2029
1.4.3 Global Molecular Diagnostic Kits Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Molecular Diagnostic Kits Market Competition by Manufacturers
2.1 Global Molecular Diagnostic Kits Sales Market Share by Manufacturers (2018-2023)
2.2 Global Molecular Diagnostic Kits Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Molecular Diagnostic Kits Average Price by Manufacturers (2018-2023)
2.4 Global Molecular Diagnostic Kits Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Molecular Diagnostic Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostic Kits, Product Type & Application
2.7 Molecular Diagnostic Kits Market Competitive Situation and Trends
2.7.1 Molecular Diagnostic Kits Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Molecular Diagnostic Kits Players Market Share by Revenue
2.7.3 Global Molecular Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Diagnostic Kits Retrospective Market Scenario by Region
3.1 Global Molecular Diagnostic Kits Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Molecular Diagnostic Kits Global Molecular Diagnostic Kits Sales by Region: 2018-2029
3.2.1 Global Molecular Diagnostic Kits Sales by Region: 2018-2023
3.2.2 Global Molecular Diagnostic Kits Sales by Region: 2024-2029
3.3 Global Molecular Diagnostic Kits Global Molecular Diagnostic Kits Revenue by Region: 2018-2029
3.3.1 Global Molecular Diagnostic Kits Revenue by Region: 2018-2023
3.3.2 Global Molecular Diagnostic Kits Revenue by Region: 2024-2029
3.4 North America Molecular Diagnostic Kits Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostic Kits Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Molecular Diagnostic Kits Sales by Country (2018-2029)
3.4.3 North America Molecular Diagnostic Kits Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Molecular Diagnostic Kits Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostic Kits Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Molecular Diagnostic Kits Sales by Country (2018-2029)
3.5.3 Europe Molecular Diagnostic Kits Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostic Kits Market Facts & Figures by Country
3.6.1 Asia Pacific Molecular Diagnostic Kits Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Molecular Diagnostic Kits Sales by Country (2018-2029)
3.6.3 Asia Pacific Molecular Diagnostic Kits Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Molecular Diagnostic Kits Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostic Kits Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Molecular Diagnostic Kits Sales by Country (2018-2029)
3.7.3 Latin America Molecular Diagnostic Kits Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostic Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostic Kits Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Molecular Diagnostic Kits Sales by Country (2018-2029)
3.8.3 Middle East and Africa Molecular Diagnostic Kits Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Molecular Diagnostic Kits Sales by Type (2018-2029)
4.1.1 Global Molecular Diagnostic Kits Sales by Type (2018-2023)
4.1.2 Global Molecular Diagnostic Kits Sales by Type (2024-2029)
4.1.3 Global Molecular Diagnostic Kits Sales Market Share by Type (2018-2029)
4.2 Global Molecular Diagnostic Kits Revenue by Type (2018-2029)
4.2.1 Global Molecular Diagnostic Kits Revenue by Type (2018-2023)
4.2.2 Global Molecular Diagnostic Kits Revenue by Type (2024-2029)
4.2.3 Global Molecular Diagnostic Kits Revenue Market Share by Type (2018-2029)
4.3 Global Molecular Diagnostic Kits Price by Type (2018-2029)
5 Segment by Application
5.1 Global Molecular Diagnostic Kits Sales by Application (2018-2029)
5.1.1 Global Molecular Diagnostic Kits Sales by Application (2018-2023)
5.1.2 Global Molecular Diagnostic Kits Sales by Application (2024-2029)
5.1.3 Global Molecular Diagnostic Kits Sales Market Share by Application (2018-2029)
5.2 Global Molecular Diagnostic Kits Revenue by Application (2018-2029)
5.2.1 Global Molecular Diagnostic Kits Revenue by Application (2018-2023)
5.2.2 Global Molecular Diagnostic Kits Revenue by Application (2024-2029)
5.2.3 Global Molecular Diagnostic Kits Revenue Market Share by Application (2018-2029)
5.3 Global Molecular Diagnostic Kits Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Molecular Diagnostic Kits Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Danaher Molecular Diagnostic Kits Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Hologic
6.3.1 Hologic Corporation Information
6.3.2 Hologic Description and Business Overview
6.3.3 Hologic Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hologic Molecular Diagnostic Kits Product Portfolio
6.3.5 Hologic Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grifols Molecular Diagnostic Kits Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 BioMérieux
6.5.1 BioMérieux Corporation Information
6.5.2 BioMérieux Description and Business Overview
6.5.3 BioMérieux Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioMérieux Molecular Diagnostic Kits Product Portfolio
6.5.5 BioMérieux Recent Developments/Updates
6.6 Qiagen
6.6.1 Qiagen Corporation Information
6.6.2 Qiagen Description and Business Overview
6.6.3 Qiagen Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qiagen Molecular Diagnostic Kits Product Portfolio
6.6.5 Qiagen Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Molecular Diagnostic Kits Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Thermo Fisher
6.8.1 Thermo Fisher Corporation Information
6.8.2 Thermo Fisher Description and Business Overview
6.8.3 Thermo Fisher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Thermo Fisher Molecular Diagnostic Kits Product Portfolio
6.8.5 Thermo Fisher Recent Developments/Updates
6.9 Bio-Rad
6.9.1 Bio-Rad Corporation Information
6.9.2 Bio-Rad Description and Business Overview
6.9.3 Bio-Rad Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bio-Rad Molecular Diagnostic Kits Product Portfolio
6.9.5 Bio-Rad Recent Developments/Updates
6.10 Illumina
6.10.1 Illumina Corporation Information
6.10.2 Illumina Description and Business Overview
6.10.3 Illumina Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Illumina Molecular Diagnostic Kits Product Portfolio
6.10.5 Illumina Recent Developments/Updates
6.11 Siemens
6.11.1 Siemens Corporation Information
6.11.2 Siemens Molecular Diagnostic Kits Description and Business Overview
6.11.3 Siemens Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Siemens Molecular Diagnostic Kits Product Portfolio
6.11.5 Siemens Recent Developments/Updates
6.12 Agilent
6.12.1 Agilent Corporation Information
6.12.2 Agilent Molecular Diagnostic Kits Description and Business Overview
6.12.3 Agilent Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Agilent Molecular Diagnostic Kits Product Portfolio
6.12.5 Agilent Recent Developments/Updates
6.13 Daangene
6.13.1 Daangene Corporation Information
6.13.2 Daangene Molecular Diagnostic Kits Description and Business Overview
6.13.3 Daangene Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Daangene Molecular Diagnostic Kits Product Portfolio
6.13.5 Daangene Recent Developments/Updates
6.14 Diasorin
6.14.1 Diasorin Corporation Information
6.14.2 Diasorin Molecular Diagnostic Kits Description and Business Overview
6.14.3 Diasorin Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Diasorin Molecular Diagnostic Kits Product Portfolio
6.14.5 Diasorin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Molecular Diagnostic Kits Description and Business Overview
6.15.3 Merck Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Merck Molecular Diagnostic Kits Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 KHB
6.16.1 KHB Corporation Information
6.16.2 KHB Molecular Diagnostic Kits Description and Business Overview
6.16.3 KHB Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.16.4 KHB Molecular Diagnostic Kits Product Portfolio
6.16.5 KHB Recent Developments/Updates
6.17 liferiver
6.17.1 liferiver Corporation Information
6.17.2 liferiver Molecular Diagnostic Kits Description and Business Overview
6.17.3 liferiver Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.17.4 liferiver Molecular Diagnostic Kits Product Portfolio
6.17.5 liferiver Recent Developments/Updates
6.18 Leadman
6.18.1 Leadman Corporation Information
6.18.2 Leadman Molecular Diagnostic Kits Description and Business Overview
6.18.3 Leadman Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Leadman Molecular Diagnostic Kits Product Portfolio
6.18.5 Leadman Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostic Kits Industry Chain Analysis
7.2 Molecular Diagnostic Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostic Kits Production Mode & Process
7.4 Molecular Diagnostic Kits Sales and Marketing
7.4.1 Molecular Diagnostic Kits Sales Channels
7.4.2 Molecular Diagnostic Kits Distributors
7.5 Molecular Diagnostic Kits Customers
8 Molecular Diagnostic Kits Market Dynamics
8.1 Molecular Diagnostic Kits Industry Trends
8.2 Molecular Diagnostic Kits Market Drivers
8.3 Molecular Diagnostic Kits Market Challenges
8.4 Molecular Diagnostic Kits Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer